Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders
Abstract
When the brain does not develop normally, the disabilities that ensue can affect a person for life. Sahin and Sur review how emerging knowledge of the molecular biology behind a suite of neurodevelopmental disorders is shedding light on the group as a whole. The new knowledge offers tantalizing leads toward more effective therapies.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 20, 2015
- Source ID
- 10.1126/science.aab3897
Entities
People
- Mriganka Sur
- Mustafa Şahin
Organizations
- Autism Speaks
- Boston Children's Hospital
- Massachusetts Institute of Technology
- Nancy Lurie Marks Family Foundation
- National Institutes of Health
- National Science Foundation
- Novartis
- Shire plc
- Simons Foundation
- Tuberous Sclerosis Alliance
- United States Department of Defense